Company · CIK 1702123

# Cardiol Therapeutics Inc.

| CIK | [1702123](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001702123) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | A6 |
| Business address | Ontario, Canada |
| Listed | CRDL (Nasdaq) |
| First annual or quarterly report | 2022-03-24 |

## Offerings

 0 registrations

No offering chain starts here after 2002-11-04: the company's filings belong to registrations filed earlier, or to drafts and notices only.

## Filings

 2

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2024-07-16 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1702123/999999999524002182/9999999995-24-002182-index.htm) Declared effective | 333-280713 | 9999999995-24-002182 |
| 2021-08-04 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1702123/999999999521003046/9999999995-21-003046-index.htm) Declared effective | 333-257764 | 9999999995-21-003046 |

[All filings of this company](https://equitycapital.markets/filings?cik=1702123) · [CSV](https://equitycapital.markets/filings.csv?cik=1702123)

---
Source page: https://equitycapital.markets/company/1702123 · Data: U.S. SEC EDGAR · CC BY 4.0